Recalls & Warnings October 09, 2013 FDA Warns Consumers Not to Use OxyElite Pro As It Investigates Link With Hepatitis On October 8, 2013, the FDA warned consumers not to buy or use USPLabs weight loss supplement OxyElite Pro because it has been linked with 24 cases of acute non-viral hepatitis in Hawaii
The FDA granted approval on December 22, 2025, making the Wegovy Pill the first oral GLP-1 specifically indicated for weight loss
Certain drug interactions between Ozempic and oral medications can influence how the body absorbs the oral drugs
The states second largest insurer, Point32Health, followed suit to limit GLP-1 coverage for weight loss
It is not medical advice and should not be used to make decisions about managing a diagnosed health condition
Professionals may recommend that you stop taking the semaglutide